Cargando…

The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis

Iron is an essential mineral needed for normal physiologic processes. While its function in oxygen transport and other important physiologic processes is well known, less is understood about its role in inflammatory diseases such as atherosclerosis. Existing paradigms suggest iron as a driver of ath...

Descripción completa

Detalles Bibliográficos
Autores principales: Habib, Anwer, Finn, Aloke V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145350/
https://www.ncbi.nlm.nih.gov/pubmed/25221512
http://dx.doi.org/10.3389/fphar.2014.00195
_version_ 1782332158954700800
author Habib, Anwer
Finn, Aloke V.
author_facet Habib, Anwer
Finn, Aloke V.
author_sort Habib, Anwer
collection PubMed
description Iron is an essential mineral needed for normal physiologic processes. While its function in oxygen transport and other important physiologic processes is well known, less is understood about its role in inflammatory diseases such as atherosclerosis. Existing paradigms suggest iron as a driver of atherosclerosis through its actions as a pro-oxidant capable of causing lipid oxidation and tissue damage. Recently we and others have identified hemoglobin (Hb) derived iron as an important factor in determining macrophage differentiation and function in areas of intraplaque hemorrhage within human atherosclerosis. Hb associated macrophages, M(Hb), are distinct from traditional macrophage foam cells because they do not contain large amounts of lipid or inflammatory cytokines, are characterized by high levels of expression of mannose receptor (CD206) and CD163 in addition to producing anti-inflammatory cytokines such as IL-10. Despite the well-known role of iron as an catalyst capable of producing lipid peroxidation through generation of reactive oxygen species (ROS) such as hydroxyl radical, we and others have shown that macrophages in areas of intraplaque hemorrhage demonstrate reduced intracellular iron and ROS which triggers production of anti-inflammatory cytokines as well as genes involved in cholesterol efflux. These data suggest that manipulation of macrophage iron itself may be a promising pharmacologic target for atherosclerosis prevention through its effects on macrophage inflammation and lipid metabolism. In this review we will summarize the current understanding of iron as it relates to plaque inflammation and discuss how further exploration of this subject may lead to new therapies for atherosclerosis.
format Online
Article
Text
id pubmed-4145350
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-41453502014-09-12 The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis Habib, Anwer Finn, Aloke V. Front Pharmacol Pharmacology Iron is an essential mineral needed for normal physiologic processes. While its function in oxygen transport and other important physiologic processes is well known, less is understood about its role in inflammatory diseases such as atherosclerosis. Existing paradigms suggest iron as a driver of atherosclerosis through its actions as a pro-oxidant capable of causing lipid oxidation and tissue damage. Recently we and others have identified hemoglobin (Hb) derived iron as an important factor in determining macrophage differentiation and function in areas of intraplaque hemorrhage within human atherosclerosis. Hb associated macrophages, M(Hb), are distinct from traditional macrophage foam cells because they do not contain large amounts of lipid or inflammatory cytokines, are characterized by high levels of expression of mannose receptor (CD206) and CD163 in addition to producing anti-inflammatory cytokines such as IL-10. Despite the well-known role of iron as an catalyst capable of producing lipid peroxidation through generation of reactive oxygen species (ROS) such as hydroxyl radical, we and others have shown that macrophages in areas of intraplaque hemorrhage demonstrate reduced intracellular iron and ROS which triggers production of anti-inflammatory cytokines as well as genes involved in cholesterol efflux. These data suggest that manipulation of macrophage iron itself may be a promising pharmacologic target for atherosclerosis prevention through its effects on macrophage inflammation and lipid metabolism. In this review we will summarize the current understanding of iron as it relates to plaque inflammation and discuss how further exploration of this subject may lead to new therapies for atherosclerosis. Frontiers Media S.A. 2014-08-27 /pmc/articles/PMC4145350/ /pubmed/25221512 http://dx.doi.org/10.3389/fphar.2014.00195 Text en Copyright © 2014 Habib and Finn. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Habib, Anwer
Finn, Aloke V.
The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis
title The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis
title_full The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis
title_fullStr The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis
title_full_unstemmed The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis
title_short The role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis
title_sort role of iron metabolism as a mediator of macrophage inflammation and lipid handling in atherosclerosis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145350/
https://www.ncbi.nlm.nih.gov/pubmed/25221512
http://dx.doi.org/10.3389/fphar.2014.00195
work_keys_str_mv AT habibanwer theroleofironmetabolismasamediatorofmacrophageinflammationandlipidhandlinginatherosclerosis
AT finnalokev theroleofironmetabolismasamediatorofmacrophageinflammationandlipidhandlinginatherosclerosis
AT habibanwer roleofironmetabolismasamediatorofmacrophageinflammationandlipidhandlinginatherosclerosis
AT finnalokev roleofironmetabolismasamediatorofmacrophageinflammationandlipidhandlinginatherosclerosis